Annual report
3391.TEDINET S100Y5EY
Period2025-03-01 → 2026-02-28
Filed2026-05-21
StandardJapan GAAP
ConsolidatedYes
Data checks21 of 22 passed
Key figures · 74
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.45T | 2025-03-01 → 2026-02-28 | Cons. | Net sales |
| Revenue | ¥845.6bn | 2024-05-16 → 2025-02-28 | Cons. | Net sales |
| Operating income | ¥63.0bn | 2025-03-01 → 2026-02-28 | Cons. | Operating income |
| Operating income | ¥37.9bn | 2024-05-16 → 2025-02-28 | Cons. | Operating income |
| Ordinary income | ¥63.1bn | 2025-03-01 → 2026-02-28 | Cons. | Ordinary income |
| Ordinary income | ¥37.8bn | 2024-05-16 → 2025-02-28 | Cons. | Ordinary income |
| Profit before tax | ¥66.3bn | 2025-03-01 → 2026-02-28 | Cons. | Income before income taxes |
| Profit before tax | ¥28.4bn | 2024-05-16 → 2025-02-28 | Cons. | Income before income taxes |
| Net income (owners) | ¥42.7bn | 2025-03-01 → 2026-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥17.2bn | 2024-05-16 → 2025-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥45.4bn | 2025-03-01 → 2026-02-28 | Cons. | Profit loss |
| Net income | ¥18.6bn | 2024-05-16 → 2025-02-28 | Cons. | Profit loss |
| Total assets | ¥1.65T | at 2026-02-28 | Cons. | Assets |
| Total assets | ¥583.4bn | at 2025-02-28 | Cons. | Assets |
| Total liabilities | ¥752.3bn | at 2026-02-28 | Cons. | Liabilities |
| Total liabilities | ¥277.0bn | at 2025-02-28 | Cons. | Liabilities |
| Net assets / equity | ¥895.7bn | at 2026-02-28 | Cons. | Net assets |
| Net assets / equity | ¥306.4bn | at 2025-02-28 | Cons. | Net assets |
| Cash and deposits | ¥202.1bn | at 2026-02-28 | Cons. | Cash and deposits |
| Cash and deposits | ¥92.7bn | at 2025-02-28 | Cons. | Cash and deposits |
| Cash & equivalents | ¥201.3bn | at 2026-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥92.6bn | at 2025-02-28 | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥84.6bn | 2025-03-01 → 2026-02-28 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥64.6bn | 2024-05-16 → 2025-02-28 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥19.8bn | 2025-03-01 → 2026-02-28 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥19.7bn | 2024-05-16 → 2025-02-28 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥39.0bn | 2025-03-01 → 2026-02-28 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥10.9bn | 2024-05-16 → 2025-02-28 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥144.55 | 2025-03-01 → 2026-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥70.73 | 2024-05-16 → 2025-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥144.08 | 2025-03-01 → 2026-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥70.55 | 2024-05-16 → 2025-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥1,932.16 | at 2026-02-28 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,155.78 | at 2025-02-28 | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 53.1% | at 2026-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.2% | at 2025-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 7.4% | 2025-03-01 → 2026-02-28 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.1% | 2024-05-16 → 2025-02-28 | Cons. | Rate of return on equity (5-year summary) |
| Employees | 27,681 | at 2026-02-28 | Cons. | Number of employees |
| Employees | 11,298 | at 2025-02-28 | Cons. | Number of employees |
| Revenue | ¥20.6bn | 2025-03-01 → 2026-02-28 | Standalone | Operating revenue2 |
| Revenue | ¥23.3bn | 2024-05-16 → 2025-02-28 | Standalone | Operating revenue2 |
| Operating income | ¥6.4bn | 2025-03-01 → 2026-02-28 | Standalone | Operating income |
| Operating income | ¥15.7bn | 2024-05-16 → 2025-02-28 | Standalone | Operating income |
| Ordinary income | ¥6.3bn | 2025-03-01 → 2026-02-28 | Standalone | Ordinary income |
| Ordinary income | ¥15.7bn | 2024-05-16 → 2025-02-28 | Standalone | Ordinary income |
| Profit before tax | ¥6.1bn | 2025-03-01 → 2026-02-28 | Standalone | Income before income taxes |
| Profit before tax | ¥16.0bn | 2024-05-16 → 2025-02-28 | Standalone | Income before income taxes |
| Net income | ¥6.5bn | 2025-03-01 → 2026-02-28 | Standalone | Profit loss |
| Net income | ¥16.1bn | 2024-05-16 → 2025-02-28 | Standalone | Profit loss |
| Total assets | ¥848.5bn | at 2026-02-28 | Standalone | Assets |
| Total assets | ¥169.3bn | at 2025-02-28 | Standalone | Assets |
| Total liabilities | ¥139.9bn | at 2026-02-28 | Standalone | Liabilities |
| Total liabilities | ¥35.1bn | at 2025-02-28 | Standalone | Liabilities |
| Net assets / equity | ¥708.6bn | at 2026-02-28 | Standalone | Net assets |
| Net assets / equity | ¥134.2bn | at 2025-02-28 | Standalone | Net assets |
| Cash and deposits | ¥24.7bn | at 2026-02-28 | Standalone | Cash and deposits |
| Cash and deposits | ¥25.0bn | at 2025-02-28 | Standalone | Cash and deposits |
| EPS (basic) | ¥22.09 | 2025-03-01 → 2026-02-28 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥66.28 | 2024-05-16 → 2025-02-28 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥22.02 | 2025-03-01 → 2026-02-28 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥66.11 | 2024-05-16 → 2025-02-28 | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥156.5 | 2025-03-01 → 2026-02-28 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥267 | 2024-05-16 → 2025-02-28 | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,558.43 | at 2026-02-28 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥548.04 | at 2025-02-28 | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 83.4% | at 2026-02-28 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.8% | at 2025-02-28 | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 1.6% | 2025-03-01 → 2026-02-28 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.2% | 2024-05-16 → 2025-02-28 | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 454,308,990 | at 2026-02-28 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 49,557,068 | at 2025-02-28 | Standalone | Total number of issued shares (5-year summary) |
| Employees | 245 | at 2026-02-28 | Standalone | Number of employees |
| Employees | 209 | at 2025-02-28 | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 1,651
| Item | Context | Value | Unit |
|---|---|---|---|
| Filer name in english | FilingDateInstant | TSURUHA HOLDINGS INC. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第三号様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Current fiscal year start date | FilingDateInstant | 2025-03-01 | |
| Current period end date | FilingDateInstant | 2026-02-28 | |
| Type of current period | FilingDateInstant | FY | |
| Current fiscal year end date | FilingDateInstant | 2026-02-28 | |
| Previous fiscal year start date | FilingDateInstant | 2024-05-16 | |
| Comparative period end date | FilingDateInstant | 2025-02-28 | |
| Previous fiscal year end date | FilingDateInstant | 2025-02-28 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Company history (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Overview of affiliated entities (text) | FilingDateInstant | Text · Plus | |
| Information about employees (text) | FilingDateInstant | Text · Plus | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row1Member | Original text (Japanese)㈱ツルハ | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row2Member | Original text (Japanese)㈱くすりの福太郎 | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row3Member | Original text (Japanese)㈱ツルハグループドラッグ＆ファーマシー西日本 | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row4Member | Original text (Japanese)㈱レデイ薬局 | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row5Member | Original text (Japanese)㈱杏林堂薬局 | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row6Member | Original text (Japanese)㈱ドラッグイレブン | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row7Member | Original text (Japanese)ウエルシア薬局㈱ | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row8Member | Original text (Japanese)ウエルシア介護サービス㈱ | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row9Member | Original text (Japanese)シミズ薬品㈱ | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row10Member | Original text (Japanese)㈱丸大サクラヰ薬局 | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row11Member | ㈱MASAYA | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row12Member | Original text (Japanese)㈱よどや | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row13Member | Original text (Japanese)㈱クスリのマルエ | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row14Member | Original text (Japanese)㈱ププレひまわり | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row15Member | Original text (Japanese)㈱コクミン | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row16Member | Original text (Japanese)㈱ふく薬品 | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row17Member | Original text (Japanese)㈱ウェルパーク | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row18Member | Original text (Japanese)ウエルシアパートナーズ㈱ | |
| Business policy business environment issues to address etc (text) | FilingDateInstant | Text · Plus | |
| Disclosure of sustainability related financial information (text) | FilingDateInstant | Text · Plus | |
| Governance (text) | FilingDateInstant | Text · Plus | |
| Strategy (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 22 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | partial |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |